Table 5. Evaluation of oxidative damage markers in liver tissue using one-way analysis of variance ANOVA.
Sampling site | Group | GSH [mmol/L] | NP-SH [mmol/L] | NP-SS-NP [mmol/L] | G-SS-NP [mmol/L] | MDA [mol/L] | 3-NT [µmol/L] |
---|---|---|---|---|---|---|---|
Left lobe | V (n=6) | 2.268±0.295 | 15.650±1.993* | 0.316 (0.242; 0.399)* | 0.094±0.062 | 36.937±2.581 | 7.211±0.298* |
P (n=6) | 1.758±0.235 | 9.751±1.052* | 1.865 (0.995; 3.707)* | 0.313±0.196 | 43.322±5.623 | 7.628±0.276* | |
Right lobe | V (n=6) | 2.302±0.479 | 13.5673.085* | 0.325 (0.220; 0.440)* | 0.124±0.105 | 37.965±3.178 | 7.448±0.196 |
P (n=6) | 1.989±0.357 | 10.033±1.671* | 1.659 (0.972; 3.129)* | 0.329±0.143 | 43.776±4.511 | 7.726±0.214 |
Values are expressed as medians (quartile Q0.25; quartile Q0.75) or as average ± standard deviation, statistically significant differences between groups at a significance level of P<0.05 are marked with *. V, intervention group; P, control group; GSH, glutathione; NP-SH, non-protein thiols; NP-SS-NP, non-protein disulfides; G-SS-NP, glutathione-mixed disulfides; MDA, malondialdehyde; 3-NT, 3-nitrotyrosine.